A P Pharma

A.P. Pharma raises $4.5 million, names new CEO

Tuesday, April 26, 2011

California-based A.P. Pharma has raised $4.5 million in convertible notes and named a new CEO, according to Silicon Valley/San Jose Business Journal.  The specialty pharmaceutical company’s lead drug candidate is designed to prevent acute-onset and delayed-onset chemotherapy-induced nausea and vomiting.

[Read More]